Keywords: novartis, certican, cleared, eu, immunosuppressant, everolimus, completed

Novartis' Certican cleared in EU

Article | 15 December 2003

Novartis' immunosuppressant Certican (everolimus) has completed theEuropean Mutual Recognition Procedure and is now approved in all 15 member states for the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Novartis

Go to company listing

Related Drugs

Cyclosporine

Neoral

Restasis

Sandimmune

Go to drug listing